Eric L. Matteson

Oct 21, 2024 | ard.bmj.com | Dario Camellino |Eric L. Matteson

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Sep 8, 2024 | acrjournals.onlinelibrary.wiley.com | Eric L. Matteson |Science Rochester Minnesota |Elisabeth Bendstrup |Aarhus Denmark

Interstitial lung disease (ILD) is a frequent manifestation of rheumatoid arthritis (RA).1-7 The reported prevalence of ILD in patients with RA varies widely depending on the population studied and the definition used, which may only require evidence of ILD on high-resolution computed tomography (HRCT) and not be restricted to clinically significant disease.

Mar 5, 2024 | the-rheumatologist.org | Eric L. Matteson |Evelyn Hsieh

Dedicated to advancing rheumatology education worldwideOn Feb. 2, 2024, distinguished professor of medicine and rheumatology Debashish Danda, MBBS, MD, DM, FRCP, was lost to the world following a tragic motor vehicle accident. Dr. Danda was highly respected both in his home country of India and on the international stage for his contributions to advancing rheumatology education and patient care, and for his broad vision of the global nature of medicine and medical progress.

Feb 28, 2024 | ard.bmj.com | Dario Camellino |Eric L. Matteson

Polymyalgia RheumaticaGiant Cell ArteritisPolymyalgia rheumatica (PMR) is the second most common inflammatory rheumatic disease after rheumatoid arthritis in persons older than 50 years,1 reaching an estimated prevalence of up to 1.5% in this age group.2 Despite its frequency, many uncertainties and misconceptions still exist about how PMR should be diagnosed and managed. In many countries, primary care appears the practical and appealing setting for the triage and treatment of patients with PMR.

Oct 31, 2023 | rheumnow.com | Eric L. Matteson

I'm Eric Matteson. I am emeritus professor of Medicine at Mayo Clinic in Rochester, Minnesota, and I would like to today talk about some of the challenges and things that we need to pursue in the future to advance our understanding of PMR and improve the treatment of patients who have polymyalgia rheumatica. I think I'd like to start by saying that even though PMR is not perceived by many physicians as a severe diagnosis, its diagnosis and management actually propose significant challenges.